Possible new TRAX shares
TRAXDilution
Known so far: no new shares from the prospectus covers read · no effective shelf · not yet read: warrants, converts, ATM.
Shelf room
- Room today none, no effective shelf
How this is worked out
Shelf room: none. No shelf registration on EDGAR was declared effective in the last 3 years, so a sale needs a new registration or a private placement.
What could become new First Tracks Biotherapeutics (TRAX) shares: options and RSUs, each with the 10-Q, 10-K, S-1 or 424B filing it comes from.
TRAX dilution ladder
Every source of new shares on record, from the filings that created it.
42M outstanding; up to 50.2M fully diluted, +19%
- Outstandingas of Oct 29, 2026 (10-Q filed Nov 3) · share count on the cover page42M
- +8.2M
Not stated in the filings we read: an ATM program, warrants, convertible notes.
Counts, sizes and prices as stated in each filing; the fully diluted count is arithmetic on them. Dollars become shares only at a price a filing states. Not advice.
Financing terms to know
None found in filings since Nov 3, 2026.
Each term is quoted from the exhibit it comes from; numbers are as stated in the filing. A flag describes a financing term. It is not investment advice.
Shares outstanding
42.0M
May 2026 to Oct 2026: from 34.9M to 42.0M.
From the share count on the cover of each 10-Q and 10-K, dated as each cover states.
Follow TRAX
New shelves, offerings, 10-Qs and 10-Ks from TRAX, explained in plain English when they reach EDGAR.
Watch TRAX in the app